Dechra Pharmaceuticals (DPH)

 

Latest News

Holding(s) in Company

RNS Number: 4177Z Dechra Pharmaceuticals PLC 14 December 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Dechr...

Total Voting Rights

RNS Number: 9739X Dechra Pharmaceuticals PLC 30 November 2017 30 November 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93...

Total Voting Rights

RNS Number: 1204V Dechra Pharmaceuticals PLC 31 October 2017 31 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93,415,750...

Result of AGM - 20 October 2017

RNS Number: 2365U Dechra Pharmaceuticals PLC 20 October 2017 Date: 20 October 2017 Dechra Pharmaceuticals PLC Results of Annual General Meeting (AGM) AGM Meeting Date: 1pm on 20 October 2017 Issued Share Capital at meeting date: 93,415,750 Number of shareholders in attendance: 12 All resolutions were passed on a show of hands. Details of the proxy v...

All News

DateHeadlineSource
24-04-17Director/PDMR ShareholdingRNS
21-04-17Holding(s) in CompanyRNS
11-04-17Additional ListingRNS
04-04-17Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
04-04-17Broker Forecast - Stifel issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
31-03-17Total Voting RightsRNS
31-03-17Licensing Agreement and Share AcquisitionRNS
23-03-17Additional ListingRNS
21-03-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
21-03-17Director/PDMR ShareholdingRNS
17-03-17Director DeclarationRNS
15-03-17Block listing Interim ReviewRNS
14-03-17Broker Forecast - RBC Capital Markets issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
07-03-17Director/PDMR ShareholdingRNS
01-03-17Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
28-02-17Total Voting RightsRNS
27-02-17Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
27-02-17Dechra underlying operating profits up StockMarketWire
27-02-17Half-Yearly Financial Report 2017RNS
23-02-17Holding(s) in CompanyRNS
31-01-17Total Voting RightsRNS
17-01-17Dechra revenues riseStockMarketWire
17-01-17Trading UpdateRNS
30-12-16Total Voting RightsRNS
15-12-16Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
05-12-16Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
05-12-16Director/PDMR ShareholdingRNS
30-11-16Director/PDMR ShareholdingRNS
30-11-16Dechra options exercised StockMarketWire
30-11-16Total Voting RightsRNS
29-11-16Exercise of LTIP optionsRNS
14-11-16Additional ListingRNS
09-11-16Appointment of Non-Executive DirectorRNS
08-11-16Holding(s) in CompanyRNS
31-10-16Total Voting RightsRNS
27-10-16Broker Forecast - Numis issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
21-10-16Dechra resolutions passed at AGMStockMarketWire
21-10-16Result of AGMRNS
21-10-16Broker Forecast - N+1 Singer issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
21-10-16Dechra on trackStockMarketWire

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account